Skip to main navigation Skip to search Skip to main content

A phase II study of α-difluoromethylornithine (DFMO) for the treatment of metastatic melanoma

  • Frank L. Meyskens
  • , Edwin M. Kingsley
  • , Theodore Glattke
  • , Lois Loescher
  • , Ann Booth

Research output: Contribution to journal › Article › peer-review

67   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'A phase II study of α-difluoromethylornithine (DFMO) for the treatment of metastatic melanoma'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science